2024-05-13 16:11:21 ET
- Biolase press release ( NASDAQ: BIOL ): Q1 GAAP EPS of -$0.36 misses by $0.19 .
- Revenue of $10.13M (-3.2% Y/Y) beats by $0.13M .
- 2024 Outlook: 2024 full-year net revenue to increase between 6% and 8% year over year to between $52 million and $53 million. This reflects the continued adoption of lasers and consumables by the dental community, including general dentists, dental specialists, dental hygienists, and group practice entities, offset by the challenging business environment.
- Positive Adjusted EBITDA results for the full year of 2024.
- Shares +11.78% .
Read the full article on Seeking Alpha
For further details see:
Biolase GAAP EPS of -$0.36 misses by $0.19, revenue of $10.13M beats by $0.13M